223 related articles for article (PubMed ID: 12385578)
41. [The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism].
Szyłło K; Smolarz B; Romanowicz-Makowska H; Przybyłowska K; Lewy J; Kulig B
Pol Merkur Lekarski; 2007 Mar; 22(129):208-10. PubMed ID: 17682677
[TBL] [Abstract][Full Text] [Related]
42. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis.
Fu C; Xing Y; Song X
Cell Biochem Biophys; 2011 Apr; 59(3):185-9. PubMed ID: 21113741
[TBL] [Abstract][Full Text] [Related]
43. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
44. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
45. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
46. Allele-specific MMP-3 transcription under in vivo conditions.
Zhu C; Odeberg J; Hamsten A; Eriksson P
Biochem Biophys Res Commun; 2006 Sep; 348(3):1150-6. PubMed ID: 16904077
[TBL] [Abstract][Full Text] [Related]
47. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
48. MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1.
Letra A; Silva RA; Menezes R; Astolfi CM; Shinohara A; de Souza AP; Granjeiro JM
Arch Oral Biol; 2007 Oct; 52(10):954-60. PubMed ID: 17537400
[TBL] [Abstract][Full Text] [Related]
49. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
50. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
[TBL] [Abstract][Full Text] [Related]
51. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
[TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
53. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
54. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
55. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Liu PY; Chen JH; Li YH; Wu HL; Shi GY
Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
[TBL] [Abstract][Full Text] [Related]
56. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
[TBL] [Abstract][Full Text] [Related]
57. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811
[TBL] [Abstract][Full Text] [Related]
60. Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms.
Fiotti N; Deiuri E; Altamura N; De Colle P; Moretti ME; Toigo G; Giansante C
Arch Gerontol Geriatr; 2009; 49 Suppl 1():83-94. PubMed ID: 19836620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]